Trial Outcomes & Findings for Adaptation Of An HPV Education Resource To Promote HPV Vaccination (NCT NCT04974619)

NCT ID: NCT04974619

Last Updated: 2024-06-04

Results Overview

A scale consisting of 19 items (Score range 0-18) assessing general HPV knowledge and 9 items (Score range 0-9) assessing HPV vaccination-specific knowledge (modified from scales by Perez et al 2016 and Waller et al 2013, respectively), using a response scale consisting of True, False, and I don't know; higher scores mean higher knowledge.

Recruitment status

COMPLETED

Target enrollment

155 participants

Primary outcome timeframe

Day 1

Results posted on

2024-06-04

Participant Flow

Participant milestones

Participant milestones
Measure
Aim 1 Only: Online Survey Group
Spanish speaking young Latino men who have sex with men (YLMSM), ages 18-26 (in Florida and Puerto Rico) will be asked to complete a Qualtrics survey. Online survey: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Aim 2 Only: Interview Group
Individual interviews will be conducted with key healthcare stakeholders (i.e.,healthcare clinical leadership, providers and staff, community-based organization staff) Interviews: In-depth interviews will be conducted with key stakeholders eliciting feedback to inform intervention content and delivery methods and identify potential facilitators and barriers to intervention implementation.
Aim 3 Only: Focus Groups or Interview Group
Each site will conduct focus groups or individual interviews with English or Spanish speaking young Latino men who have sex with men (YLMSM). Focus groups and/or individual interviews will be conducted in-person and/or remotely to receive feedback on the HPV vaccine education materials. Focus groups and/or individual interviews will be conducted with 24 young adult Latino men who have sex with men (YLMSM) in either English or Spanish (approximately 12 in Puerto Rico and approximately 12 in Florida). The purpose will be to gain feedback on the acceptability, accessibility, content, delivery preference, and aesthetics of the theoretically informed HPV education materials culturally targeted for Spanish- and/or English-speaking YLMSM.
Overall Study
STARTED
117
21
17
Overall Study
COMPLETED
117
20
15
Overall Study
NOT COMPLETED
0
1
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Aim 1 Only: Online Survey Group
Spanish speaking young Latino men who have sex with men (YLMSM), ages 18-26 (in Florida and Puerto Rico) will be asked to complete a Qualtrics survey. Online survey: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Aim 2 Only: Interview Group
Individual interviews will be conducted with key healthcare stakeholders (i.e.,healthcare clinical leadership, providers and staff, community-based organization staff) Interviews: In-depth interviews will be conducted with key stakeholders eliciting feedback to inform intervention content and delivery methods and identify potential facilitators and barriers to intervention implementation.
Aim 3 Only: Focus Groups or Interview Group
Each site will conduct focus groups or individual interviews with English or Spanish speaking young Latino men who have sex with men (YLMSM). Focus groups and/or individual interviews will be conducted in-person and/or remotely to receive feedback on the HPV vaccine education materials. Focus groups and/or individual interviews will be conducted with 24 young adult Latino men who have sex with men (YLMSM) in either English or Spanish (approximately 12 in Puerto Rico and approximately 12 in Florida). The purpose will be to gain feedback on the acceptability, accessibility, content, delivery preference, and aesthetics of the theoretically informed HPV education materials culturally targeted for Spanish- and/or English-speaking YLMSM.
Overall Study
Lost to Follow-up
0
0
1
Overall Study
Withdrawal by Subject
0
0
1
Overall Study
Protocol Violation
0
1
0

Baseline Characteristics

Adaptation Of An HPV Education Resource To Promote HPV Vaccination

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Aim 1 Only: Online Survey Group
n=117 Participants
Spanish speaking young Latino men who have sex with men (YLMSM), ages 18-26 (in Florida and Puerto Rico) will be asked to complete a Qualtrics survey. Online survey: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Aim 2 Only: Interview Group
n=21 Participants
Individual interviews will be conducted with key healthcare stakeholders (i.e.,healthcare clinical leadership, providers and staff, community-based organization staff) Interviews: In-depth interviews will be conducted with key stakeholders eliciting feedback to inform intervention content and delivery methods and identify potential facilitators and barriers to intervention implementation.
Aim 3 Only: Focus Groups or Interview Group
n=17 Participants
Each site will conduct focus groups or individual interviews with English or Spanish speaking young Latino men who have sex with men (YLMSM). Focus groups and/or individual interviews will be conducted in-person and/or remotely to receive feedback on the HPV vaccine education materials. Focus groups and/or individual interviews will be conducted with 24 young adult Latino men who have sex with men (YLMSM) in either English or Spanish (approximately 12 in Puerto Rico and approximately 12 in Florida). The purpose will be to gain feedback on the acceptability, accessibility, content, delivery preference, and aesthetics of the theoretically informed HPV education materials culturally targeted for Spanish- and/or English-speaking YLMSM.
Total
n=155 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Age, Categorical
Between 18 and 65 years
117 Participants
n=5 Participants
21 Participants
n=7 Participants
17 Participants
n=5 Participants
155 Participants
n=4 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Sex/Gender, Customized
Male
117 Participants
n=5 Participants
12 Participants
n=7 Participants
17 Participants
n=5 Participants
146 Participants
n=4 Participants
Sex/Gender, Customized
Female
0 Participants
n=5 Participants
6 Participants
n=7 Participants
0 Participants
n=5 Participants
6 Participants
n=4 Participants
Sex/Gender, Customized
Unknown
0 Participants
n=5 Participants
3 Participants
n=7 Participants
0 Participants
n=5 Participants
3 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
117 Participants
n=5 Participants
11 Participants
n=7 Participants
17 Participants
n=5 Participants
145 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
n=5 Participants
6 Participants
n=7 Participants
0 Participants
n=5 Participants
6 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
4 Participants
n=7 Participants
0 Participants
n=5 Participants
4 Participants
n=4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
1 Participants
n=4 Participants
Race (NIH/OMB)
Asian
1 Participants
n=5 Participants
2 Participants
n=7 Participants
0 Participants
n=5 Participants
3 Participants
n=4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
2 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
2 Participants
n=4 Participants
Race (NIH/OMB)
Black or African American
26 Participants
n=5 Participants
2 Participants
n=7 Participants
0 Participants
n=5 Participants
28 Participants
n=4 Participants
Race (NIH/OMB)
White
52 Participants
n=5 Participants
7 Participants
n=7 Participants
2 Participants
n=5 Participants
61 Participants
n=4 Participants
Race (NIH/OMB)
More than one race
10 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
10 Participants
n=4 Participants
Race (NIH/OMB)
Unknown or Not Reported
25 Participants
n=5 Participants
10 Participants
n=7 Participants
15 Participants
n=5 Participants
50 Participants
n=4 Participants
Region of Enrollment
Puerto Rico
96 participants
n=5 Participants
11 participants
n=7 Participants
13 participants
n=5 Participants
120 participants
n=4 Participants
Region of Enrollment
United States
21 participants
n=5 Participants
10 participants
n=7 Participants
4 participants
n=5 Participants
35 participants
n=4 Participants

PRIMARY outcome

Timeframe: Day 1

Population: Unvaccinated participants only

A scale consisting of 19 items (Score range 0-18) assessing general HPV knowledge and 9 items (Score range 0-9) assessing HPV vaccination-specific knowledge (modified from scales by Perez et al 2016 and Waller et al 2013, respectively), using a response scale consisting of True, False, and I don't know; higher scores mean higher knowledge.

Outcome measures

Outcome measures
Measure
Aim 1 Only: Online Survey Group
n=102 Participants
Spanish speaking young Latino men who have sex with men (YLMSM), ages 18-26 (in Florida and Puerto Rico) will be asked to complete a Qualtrics survey. Online survey: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Part 1: HPV Vaccine Knowledge (Aim 1)
HPV Knowledge (Scale Score range 0-18)
10.10 score on a scale
Standard Deviation 4.87
Part 1: HPV Vaccine Knowledge (Aim 1)
HPV Vaccination Knowledge Scale (Score range 0-9)
3.19 score on a scale
Standard Deviation 2.56

PRIMARY outcome

Timeframe: Day 1

A scale consisting of 2 items from the Health Information National Trends Survey (HINTS) 2018, with response options Yes or No; Positive responses mean higher awareness

Outcome measures

Outcome measures
Measure
Aim 1 Only: Online Survey Group
n=102 Participants
Spanish speaking young Latino men who have sex with men (YLMSM), ages 18-26 (in Florida and Puerto Rico) will be asked to complete a Qualtrics survey. Online survey: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Part 1: HPV Vaccine Awareness (Aim 1)
Ever Heard of HPV? · No
21 Participants
Part 1: HPV Vaccine Awareness (Aim 1)
Ever Heard of HPV? · Yes
81 Participants
Part 1: HPV Vaccine Awareness (Aim 1)
Ever Heard of HPV Vaccine? · No
45 Participants
Part 1: HPV Vaccine Awareness (Aim 1)
Ever Heard of HPV Vaccine? · Yes
57 Participants

PRIMARY outcome

Timeframe: Day 1

A scale consisting of 8 items modified from the Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS); with a 5-point response scale ranging from strongly disagree to strongly agree; higher scores mean stronger attitudes. The possible scale score range = 8-40.

Outcome measures

Outcome measures
Measure
Aim 1 Only: Online Survey Group
n=102 Participants
Spanish speaking young Latino men who have sex with men (YLMSM), ages 18-26 (in Florida and Puerto Rico) will be asked to complete a Qualtrics survey. Online survey: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Part 1: HPV Vaccine Attitude (Aim 1)
27.38 score on a scale
Standard Deviation 4.36

PRIMARY outcome

Timeframe: Day 1

Participants will complete scales; a. Perceived Risk 5 point scale from no chance to Certain I will get; higher scores mean higher perceived risk; b. Descriptive norms scale from 0% to 100%, higher score mean greater descriptive norms; c. Perceived norms 8 point scale ranging from strongly disagree to strongly agree, not applicable, higher scores mean stronger perceived norms; d. Perceived Barriers 3-point scale ranging from Not concerned at all to Very concerned, higher scores mean higher perceived barriers; e. Self-efficacy scale ranging from Strongly agree to Strongly Disagree; lower scores mean higher self-efficacy.

Outcome measures

Outcome measures
Measure
Aim 1 Only: Online Survey Group
n=102 Participants
Spanish speaking young Latino men who have sex with men (YLMSM), ages 18-26 (in Florida and Puerto Rico) will be asked to complete a Qualtrics survey. Online survey: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Part 1: HPV Vaccine Health Beliefs 1 (Aim 1)
What percentage of female peers have received the HPV vaccine? Possible Scale Range 0-100
24.71 score on a scale
Standard Deviation 26.62
Part 1: HPV Vaccine Health Beliefs 1 (Aim 1)
Perceived Risk. 5 point scale with of Possible scale range 5-40
22.81 score on a scale
Standard Deviation 10.93
Part 1: HPV Vaccine Health Beliefs 1 (Aim 1)
What percentage of peers do you think have received the HPV vaccine? Possible scale Range 0-100
20.01 score on a scale
Standard Deviation 22.78
Part 1: HPV Vaccine Health Beliefs 1 (Aim 1)
What percentage of male peers do you think have received HPV vaccine? Possible scale Range 0-100
16.26 score on a scale
Standard Deviation 20.03
Part 1: HPV Vaccine Health Beliefs 1 (Aim 1)
What percentage of gay/bisexual males do you think have received HPV vaccine? Possible Range 1-100
16.67 score on a scale
Standard Deviation 19.95
Part 1: HPV Vaccine Health Beliefs 1 (Aim 1)
What percentage of gay/bisexual females received the HPV vaccine? Possible Scale Range 0-100
20.25 score on a scale
Standard Deviation 23.02
Part 1: HPV Vaccine Health Beliefs 1 (Aim 1)
Perceived Norms. 8 items. Possible Score range 8-40
26.55 score on a scale
Standard Deviation 8.65
Part 1: HPV Vaccine Health Beliefs 1 (Aim 1)
Perceived Barriers. 3 items. Possible score range 3-15.
7.19 score on a scale
Standard Deviation 3.01
Part 1: HPV Vaccine Health Beliefs 1 (Aim 1)
SELFEFF1 - SELFEFF9. 9 items. Possible Score range 9-45.
17.75 score on a scale
Standard Deviation 7.05

PRIMARY outcome

Timeframe: Day 1

Population: Participants in analysis are unvaccinated.

Count of participants who responded what they thought their perceived risk is contracting HPV. Questions range from Much below average, below average, average risk, above average risk, much above average risk, and I don't know.

Outcome measures

Outcome measures
Measure
Aim 1 Only: Online Survey Group
n=102 Participants
Spanish speaking young Latino men who have sex with men (YLMSM), ages 18-26 (in Florida and Puerto Rico) will be asked to complete a Qualtrics survey. Online survey: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Part 1: HPV Vaccine Health Beliefs 2 (Aim 1)
Much below average
27 Participants
Part 1: HPV Vaccine Health Beliefs 2 (Aim 1)
Below average
14 Participants
Part 1: HPV Vaccine Health Beliefs 2 (Aim 1)
Average risk (Same risk as others your age)
29 Participants
Part 1: HPV Vaccine Health Beliefs 2 (Aim 1)
Above average
6 Participants
Part 1: HPV Vaccine Health Beliefs 2 (Aim 1)
Much above average
5 Participants
Part 1: HPV Vaccine Health Beliefs 2 (Aim 1)
I don't know
21 Participants

PRIMARY outcome

Timeframe: Day 1

Population: Participants in analysis are unvaccinated.

Count of participants who responded within each category asking intention to get HPV vaccine among those unvaccinated, using a 7-point scale ranging from Very unlikely to Very likely, higher scores mean stronger intentions.

Outcome measures

Outcome measures
Measure
Aim 1 Only: Online Survey Group
n=102 Participants
Spanish speaking young Latino men who have sex with men (YLMSM), ages 18-26 (in Florida and Puerto Rico) will be asked to complete a Qualtrics survey. Online survey: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to get information about the HPV vaccine · Very Unlikey
15 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to get information about the HPV vaccine · Somewhat Unlikely
2 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to get information about the HPV vaccine · A Little Unlikely
5 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to get information about the HPV vaccine · Neither Unikely nor Likely
13 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to get information about the HPV vaccine · A Little Likely
5 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to get information about the HPV vaccine · Somewhat Likely
26 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to get information about the HPV vaccine · Very Likely
36 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to obtain more than 1 shot in the next 12 months, · Very Unlikey
14 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to obtain more than 1 shot in the next 12 months, · Somewhat Unlikely
5 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to obtain more than 1 shot in the next 12 months, · A Little Unlikely
5 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to obtain more than 1 shot in the next 12 months, · Neither Unikely nor Likely
27 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to obtain more than 1 shot in the next 12 months, · A Little Likely
8 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to obtain more than 1 shot in the next 12 months, · Somewhat Likely
31 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to obtain more than 1 shot in the next 12 months, · Very Likely
12 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to get more than one dose in the future · Very Unlikey
12 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to get more than one dose in the future · Somewhat Unlikely
9 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to get more than one dose in the future · A Little Unlikely
4 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to get more than one dose in the future · Neither Unikely nor Likely
20 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to get more than one dose in the future · A Little Likely
2 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to get more than one dose in the future · Somewhat Likely
24 Participants
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)
Intention to get more than one dose in the future · Very Likely
31 Participants

PRIMARY outcome

Timeframe: Day 1

Population: Missing data from 79 participants because orginal survey did not include this item, due to eligibility criteria at the time.

Count of participants who responded within each category that assesses past receipt of the HPV vaccine (modified from Brewer et al., 2009 and Brewer et al., 2017). Responses were: Yes, No, I don't know.

Outcome measures

Outcome measures
Measure
Aim 1 Only: Online Survey Group
n=23 Participants
Spanish speaking young Latino men who have sex with men (YLMSM), ages 18-26 (in Florida and Puerto Rico) will be asked to complete a Qualtrics survey. Online survey: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Part 1: HPV Vaccine Behaviors 1 (Aim 1)
Yes
0 Participants
Part 1: HPV Vaccine Behaviors 1 (Aim 1)
No
17 Participants
Part 1: HPV Vaccine Behaviors 1 (Aim 1)
I Don't Know
6 Participants

PRIMARY outcome

Timeframe: Day 1

Population: Analysis is of vaccinated participants

Count of participants that self reported number of shots received among vaccinated individuals. Items range from 1 shot to I don't know.

Outcome measures

Outcome measures
Measure
Aim 1 Only: Online Survey Group
n=8 Participants
Spanish speaking young Latino men who have sex with men (YLMSM), ages 18-26 (in Florida and Puerto Rico) will be asked to complete a Qualtrics survey. Online survey: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Part 1: HPV Vaccine Behaviors 2 (Aim 1)
1 Shot
2 Participants
Part 1: HPV Vaccine Behaviors 2 (Aim 1)
2 Shots
1 Participants
Part 1: HPV Vaccine Behaviors 2 (Aim 1)
3 Shots
1 Participants
Part 1: HPV Vaccine Behaviors 2 (Aim 1)
At Least 1 Shot, But I Don't Know How Many
1 Participants
Part 1: HPV Vaccine Behaviors 2 (Aim 1)
At Least 2 Shots, But I Don't Know How Many
1 Participants
Part 1: HPV Vaccine Behaviors 2 (Aim 1)
I Don't Know
2 Participants

PRIMARY outcome

Timeframe: Day 1

A scale developed by Christy (unpublished) assessing HPV vaccine education preferences. The survey question, "Who would you like to receive information from?". Options were Physician, Other healthcare provider (Nurse, Medical Assistant), Female peer, Male peer, Parent of teen, Parent of young adult, Someone who has survived an HPV-related Cancer Other. Participants marked all that applied.

Outcome measures

Outcome measures
Measure
Aim 1 Only: Online Survey Group
n=102 Participants
Spanish speaking young Latino men who have sex with men (YLMSM), ages 18-26 (in Florida and Puerto Rico) will be asked to complete a Qualtrics survey. Online survey: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Part 1: HPV Vaccine Educational Preferences 1 (Aim 1)
Physicians
96 Participants
Part 1: HPV Vaccine Educational Preferences 1 (Aim 1)
Other Healthcare Providers
59 Participants
Part 1: HPV Vaccine Educational Preferences 1 (Aim 1)
Female Peer
8 Participants
Part 1: HPV Vaccine Educational Preferences 1 (Aim 1)
Male Peer
19 Participants
Part 1: HPV Vaccine Educational Preferences 1 (Aim 1)
Parent of Teen
3 Participants
Part 1: HPV Vaccine Educational Preferences 1 (Aim 1)
Parent of Young Adult
4 Participants
Part 1: HPV Vaccine Educational Preferences 1 (Aim 1)
HPV Cancer Survivor
40 Participants
Part 1: HPV Vaccine Educational Preferences 1 (Aim 1)
Other
2 Participants

PRIMARY outcome

Timeframe: Day 1

Items developed by Christy (unpublished) assessing HPV vaccine education preferences. The survey question, "Best method for delivering education?". 1 being the best method and 8 being the worst method.

Outcome measures

Outcome measures
Measure
Aim 1 Only: Online Survey Group
n=102 Participants
Spanish speaking young Latino men who have sex with men (YLMSM), ages 18-26 (in Florida and Puerto Rico) will be asked to complete a Qualtrics survey. Online survey: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
In Person · 1
55 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
In Person · 2
6 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
In Person · 3
3 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
In Person · 4
7 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
In Person · 5
8 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
In Person · 6
1 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
In Person · 7
10 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
In Person · 8
12 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Website · 1
13 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Website · 2
26 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Website · 3
18 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Website · 4
14 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Website · 5
9 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Website · 6
7 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Website · 7
8 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Website · 8
7 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Smart Phone App · 1
1 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Smart Phone App · 2
11 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Smart Phone App · 3
17 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Smart Phone App · 4
8 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Smart Phone App · 5
15 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Smart Phone App · 6
13 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Smart Phone App · 7
18 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Smart Phone App · 8
19 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Online Webinar · 1
2 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Online Webinar · 2
15 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Online Webinar · 3
14 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Online Webinar · 4
25 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Online Webinar · 5
15 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Online Webinar · 6
13 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Online Webinar · 7
9 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Online Webinar · 8
9 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Text Message · 1
6 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Text Message · 2
10 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Text Message · 3
13 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Text Message · 4
12 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Text Message · 5
11 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Text Message · 6
14 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Text Message · 7
19 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Text Message · 8
17 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Printed Booklet · 1
2 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Printed Booklet · 2
13 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Printed Booklet · 3
7 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Printed Booklet · 4
9 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Printed Booklet · 5
23 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Printed Booklet · 6
19 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Printed Booklet · 7
15 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Printed Booklet · 8
14 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Social Media Platform · 1
13 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Social Media Platform · 2
10 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Social Media Platform · 3
16 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Social Media Platform · 4
16 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Social Media Platform · 5
7 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Social Media Platform · 6
16 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Social Media Platform · 7
13 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Social Media Platform · 8
11 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Healthcare System Portal · 1
10 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Healthcare System Portal · 2
11 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Healthcare System Portal · 3
14 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Healthcare System Portal · 4
11 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Healthcare System Portal · 5
14 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Healthcare System Portal · 6
19 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Healthcare System Portal · 7
10 Participants
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)
Healthcare System Portal · 8
13 Participants

PRIMARY outcome

Timeframe: Day 1

An item developed by Christy (unpublished) assessing HPV vaccine education preferences. The survey question, "What age would it be most helpful to for a person to receive educational information?"

Outcome measures

Outcome measures
Measure
Aim 1 Only: Online Survey Group
n=102 Participants
Spanish speaking young Latino men who have sex with men (YLMSM), ages 18-26 (in Florida and Puerto Rico) will be asked to complete a Qualtrics survey. Online survey: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Part 1: HPV Vaccine Educational Preferences 3 (Aim 1)
Ages 9-10 · Missing
89 Participants
Part 1: HPV Vaccine Educational Preferences 3 (Aim 1)
Ages 9-10 · Check
13 Participants
Part 1: HPV Vaccine Educational Preferences 3 (Aim 1)
Ages 11-14 · Missing
74 Participants
Part 1: HPV Vaccine Educational Preferences 3 (Aim 1)
Ages 11-14 · Check
28 Participants
Part 1: HPV Vaccine Educational Preferences 3 (Aim 1)
Ages 15-17 · Missing
49 Participants
Part 1: HPV Vaccine Educational Preferences 3 (Aim 1)
Ages 15-17 · Check
53 Participants
Part 1: HPV Vaccine Educational Preferences 3 (Aim 1)
Ages 18-22 · Missing
50 Participants
Part 1: HPV Vaccine Educational Preferences 3 (Aim 1)
Ages 18-22 · Check
52 Participants
Part 1: HPV Vaccine Educational Preferences 3 (Aim 1)
Ages 23-30 · Missing
70 Participants
Part 1: HPV Vaccine Educational Preferences 3 (Aim 1)
Ages 23-30 · Check
32 Participants
Part 1: HPV Vaccine Educational Preferences 3 (Aim 1)
Ages 30-45 · Missing
84 Participants
Part 1: HPV Vaccine Educational Preferences 3 (Aim 1)
Ages 30-45 · Check
18 Participants
Part 1: HPV Vaccine Educational Preferences 3 (Aim 1)
I Do Not Think So · Missing
102 Participants
Part 1: HPV Vaccine Educational Preferences 3 (Aim 1)
I Do Not Think So · Check
0 Participants

PRIMARY outcome

Timeframe: Day 1

Number of participants who consented and participated in individual interviews.

Outcome measures

Outcome measures
Measure
Aim 1 Only: Online Survey Group
n=21 Participants
Spanish speaking young Latino men who have sex with men (YLMSM), ages 18-26 (in Florida and Puerto Rico) will be asked to complete a Qualtrics survey. Online survey: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Part 2: Facilitators and Barriers to Intervention Implementation (Aim 2)
20 Participants

PRIMARY outcome

Timeframe: Day 1

Number of Participants who completed either an individual interview or participated in a focus group.

Outcome measures

Outcome measures
Measure
Aim 1 Only: Online Survey Group
n=17 Participants
Spanish speaking young Latino men who have sex with men (YLMSM), ages 18-26 (in Florida and Puerto Rico) will be asked to complete a Qualtrics survey. Online survey: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Part 3: Feedback From Focus Groups or Individual Interviews (Aim 3)
13 Participants

Adverse Events

Aim 1 Only: Online Survey Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Aim 2 Only: Interview Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Aim 3 Only: Focus Groups/Individual Interviews

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Shannon Christy

Moffitt Cancer Center

Phone: 813-745-8840

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place